MedPath

Pilates: fitness fad or next frontier in falls prevention and bone health? A pilot randomised controlled trial.

Not Applicable
Recruiting
Conditions
Accidental falls
Osteopenia
Osteoporosis
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Injuries and Accidents - Other injuries and accidents
Musculoskeletal - Other muscular and skeletal disorders
Registration Number
ACTRN12612000224820
Lead Sponsor
Faculty of Medicine, Nursing and Health Sciences Strategic Grant Scheme Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Arms 1, 2, 3 and 4:
Community-dwelling men and women (i) identified as being at high risk of suffering a fall related injury on screening assessment; (ii) aged 60 years or over; and (iii) able to negotiate a set of 10 stairs independently without a gait aid. Medical clearance will be required from each participant's Medical practitioner to certify him/her as able to participate in moderate intensity physiotherapist supervised exercise before being accepted into the trial.

And:

Arm 2 and 4:
Community-dwelling men and women that have low bone mineral density (t-score > 1SD below age related normal score) as diagnosed from a DXA scan within the last 6 months at a selected imaging centre.

Exclusion Criteria

Arm 1, 2, 3 and 4:
Participants will be excluded if they: (i) have a telephone Mini-Mental State Examination score of <17; (ii) are already attending Pilates or other formal exercise class (60 minutes or more per week) for 4 or more weeks in the previous 12 weeks; (iii) currently or recently have or have had an acute medical condition; (iv) have had cancer within the past 5 years and/or currently undergoing active treatment for cancer or (v) suffering from uncontrolled chronic conditions that would interfere with the safety and conduct of the assessments or Pilates exercise intervention.

Arm 2 and 4: As stated above with the additional exclusion criteria of: (i) have received hormone therapy in the last 2 years; or (ii) have commenced taking medication(s) known to affect bone metabolism in the previous 90 days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Arm 1, 2, 3 and 4:<br>Number of falls assessed by the rate of falls (per-person-per-year). Falls will be recorded on the participants falls diary and verified by the monthly telephone follow-up.[At baseline, and 12 and 24 weeks after intervention commencement];Arm 1, 2, 3 and 4:<br>Change to standing balance as measured by seven physical performance tests proven to be valid and reliable measures of balance: 1. The Step Test 2. Functional Reach test 3. Timed Up & Go 4. Lateral Reach test 5. Clinical test of Sensory Interaction on Balance 6. Dynamic Gait Index 7. Four Square Step test[At baseline, and 12 and 24 weeks after intervention commencement];Arm 2 and 4:<br>Change in lumbar spine (L2-L4) and femoral neck bone mineral density as assessed via Dual-emission X-ray absorptiometry (DXA).[At baseline and at 24-28 weeks after the baseline assessment after the intervention commencement.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath